Associated Collaboration with the New York Genome Center to Expand Patient Access to Advanced Genomic Technologies New York — Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients, in order to identify genetic alterations driving disease […]
Continued expansion of clinical products further advances precision medicine globally The NextSeq 550Dx received approval from China’s National Medical Products Administration (NMPA) for genetic testing and diagnosis, paving the way toward improved patient outcomes by harnessing the power of next-generation sequencing. Since obtaining United States FDA approval in 2017, the NextSeq 550Dx has been cleared […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment. Regulus has utilized two Bio-Techne branded product lines, ProteinSimple and Exosome Diagnostics, to aid in their clinical trial patient testing. RGLS4326 […]
DUBLIN, Ireland & Frankfurt a.M., Germany: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Vivlion GmbH, a startup company providing next generation CRISPR/Cas gRNA libraries and screening services for the global R&D market, today announced a non-exclusive license agreement granting Vivlion® […]
Combination of free user-friendly web tool, to obtain custom probe sequences, and enzyme-based technology allows for efficient depletion of abundant RNAs for virtually any organism and sample type. IPSWICH, MA: Today, New England Biolabs (NEB®) announced further expansion of its RNA depletion product portfolio with the launch of the NEBNext Custom RNA Depletion Design Tool […]
Sanyou signs two commercial-use licenses for Horizon’s gene-edited CHO-K1 GS knockout cell line, for use in biotherapeutic pipeline development and contract research services Cambridge, UK, and Shanghai, China: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, […]
Molecular Imaging Platform Leverages Hyb & Seq Chemistry to Spatially Profile Expression of 1,000+ Genes at Single Cell and Sub-Cell Resolution Across Tissue Samples Available in Technology Access Program in H1-2021 with Commercial Instrument Launch Expected in H2-2022 Details to be Shared During Investor and Analyst Day on Tuesday, December 1st SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), […]
Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina® Focus Panel, AmpliSeq™ for Illumina® Myeloid Panel and the TruSight™ Hereditary Cancer […]
Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Dr. Muthu Meyyappan as Chief Commercial Officer (CCO), effective immediately. Muthu will lead all aspects of Congenica’s sales and marketing and will be based in Boston, MA. […]
Increased yield can drive disposable costs for MinION to $35/Gb and for PacBio to <$10/Gb Fire Monkey version 8 (FMv8) record-breaking 30Gb+ yield of raw DNA data from an E. Coli sample on a single Oxford Nanopore Technologies (ONT) MinION flow cell (Fig. 1) Increased yield boosts DNA recovery and improves sequencing (Fig. 2) Based […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
